Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine
-
Published:2022-11
Issue:
Volume:25
Page:101514
-
ISSN:1936-5233
-
Container-title:Translational Oncology
-
language:en
-
Short-container-title:Translational Oncology
Author:
Carloni RiccardoORCID,
Rizzo AlessandroORCID,
Ricci Angela Dalia,
Federico Alessandro DiORCID,
De Luca RaffaeleORCID,
Guven Deniz CanORCID,
Yalcin Suayib,
Brandi Giovanni
Subject
Cancer Research,Oncology
Reference95 articles.
1. Cholangiocarcinoma 2020: the next horizon in mechanisms and management;Banales;Nat. Rev. Gastroenterol. Hepatol.,2020
2. Current perspectives on the surgical management of perihilar cholangiocarcinoma;Hewitt;Cancers (Basel),2022
3. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study;Primrose;Lancet Oncol.,2019
4. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial;Lamarca;Lancet Oncol.,2021
5. Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up †;Valle;Ann. Oncol.,2016
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献